How is ceftriaxone administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Administration Guidelines

Ceftriaxone should be administered intravenously by infusion over a period of 30 minutes or intramuscularly, with dosing typically once daily for most adult infections due to its long half-life. 1, 2

Routes of Administration

  • Ceftriaxone can be administered via two routes:
    • Intravenous (IV): Administered by infusion over 30 minutes 1
    • Intramuscular (IM): Completely absorbed following administration with peak plasma concentrations occurring between 2-3 hours post-dosing 2, 3

Intravenous Administration

  • Reconstitute with appropriate IV diluent (sterile water for injection, 0.9% sodium chloride, or 5% dextrose) 1
  • Recommended concentration is between 10-40 mg/mL 1
  • For standard vial reconstitution:
    • 250 mg vial: Add 2.4 mL diluent
    • 500 mg vial: Add 4.8 mL diluent
    • 1 gram vial: Add 9.6 mL diluent
    • 2 gram vial: Add 19.2 mL diluent 1
  • After reconstitution, each 1 mL contains approximately 100 mg of ceftriaxone 1
  • Administer over 30 minutes for adults and children 1
  • For neonates, administer over 60 minutes to reduce risk of bilirubin encephalopathy 1

Intramuscular Administration

  • Reconstitute with appropriate diluent to achieve concentration of 250 mg/mL or 350 mg/mL 1
  • For standard vial reconstitution to 250 mg/mL:
    • 250 mg vial: Add 0.9 mL diluent
    • 500 mg vial: Add 1.8 mL diluent
    • 1 gram vial: Add 3.6 mL diluent
    • 2 gram vial: Add 7.2 mL diluent 1
  • Inject well within the body of a relatively large muscle 1
  • Aspiration before injection helps avoid unintentional injection into a blood vessel 1

Dosing Guidelines

Adult Dosing

  • Standard adult daily dose: 1-2 grams given once daily (or divided twice daily) depending on infection type and severity 4
  • For bacterial meningitis: 2 grams IV every 12 hours 4
  • For uncomplicated gonococcal infections: Single 250 mg IM dose 4
  • For preoperative prophylaxis: Single 1 gram IV dose 30 minutes to 2 hours before surgery 1

Pediatric Dosing

  • For most infections: 50-75 mg/kg/day given once daily or divided twice daily 1
  • For meningitis: Initial dose of 100 mg/kg (not exceeding 4 grams), then 100 mg/kg/day (not exceeding 4 grams daily) 1
  • Total daily dose should not exceed 2 grams for most infections and 4 grams for meningitis 1

Compatibility and Storage

  • Do not use diluents containing calcium (e.g., Ringer's solution or Hartmann's solution) due to risk of particulate formation 1
  • Incompatible with vancomycin, amsacrine, aminoglycosides, and fluconazole in admixtures 1
  • When administering these drugs concomitantly, give sequentially with thorough flushing of IV lines between administrations 1
  • After reconstitution, IV solutions remain stable for:
    • 2 days at room temperature (25°C)
    • 10 days when refrigerated (4°C) 1
  • Reconstituted IM solutions remain stable for:
    • 24 hours at room temperature with most diluents
    • 3-10 days when refrigerated, depending on diluent 1

Special Considerations

  • No dosage adjustment is necessary for elderly patients or those with impaired renal or hepatic function when using up to 2 grams per day 1, 3
  • Multiple dosing at 12- or 24-hour intervals results in 15-36% accumulation of ceftriaxone in plasma 2, 3
  • The long half-life (5.8-8.7 hours) allows for once-daily dosing in most adults, which can provide cost savings and improved convenience 3, 5
  • For patients on hemodialysis, plasma concentrations should be monitored as elimination rate may be significantly reduced in some patients 3

By following these administration guidelines, ceftriaxone can be effectively used to treat a wide range of serious infections with minimal adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacokinetic profile of ceftriaxone in man.

The American journal of medicine, 1984

Guideline

Ceftriaxone Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.